Neuroprotection by delayed triple therapy following sarin nerve agent insult in the rat
- 1. Department of Pharmacology, Israel Institute for Biological, Chemical and Environmental Sciences, Ness-Ziona 74100 (Israel)
Description
Highlights: • Exposure to the nerve agent sarin induces status epilepticus refractive seizures. • Late benzodiazepine treatment is insufficient in mitigating refractive seizures. • Combination of midazolam, ketamine and valproate attenuates refractive seizures. • A 1 h delayed combined treatment alleviates the epileptiform seizure activity. • The combined treatment prevents biochemical and histopathological neurotoxicity. The development of refractory status epilepticus (SE) induced by sarin intoxication presents a therapeutic challenge. In our current research we evaluate the efficacy of a delayed combined triple treatment in ending the abnormal epileptiform seizure activity (ESA) and the ensuing of long-term neuronal insult. SE was induced in male Sprague-Dawley rats by exposure to 1.2LD50 sarin insufficiently treated by atropine and TMB4 (TA) 1 min later. Triple treatment of ketamine, midazolam and valproic acid was administered 30 min or 1 h post exposure and was compared to a delayed single treatment with midazolam alone. Toxicity and electrocorticogram activity were monitored during the first week and behavioral evaluation performed 3 weeks post exposure followed by brain biochemical and immunohistopathological analyses. The addition of both single and triple treatments reduced mortality and enhanced weight recovery compared to the TA-only treated group. The triple treatment also significantly minimized the duration of the ESA, reduced the sarin-induced increase in the neuroinflammatory marker PGE2, the brain damage marker TSPO, decreased the gliosis, astrocytosis and neuronal damage compared to the TA+ midazolam or only TA treated groups. Finally, the triple treatment eliminated the sarin exposed increased open field activity, as well as impairing recognition memory as seen in the other experimental groups. The delayed triple treatment may serve as an efficient therapy, which prevents brain insult propagation following sarin-induced refractory SE, even if treatment is postponed for up to 1 h.
Availability note (English)
Available from http://dx.doi.org/10.1016/j.taap.2021.115519Additional details
Identifiers
- DOI
- 10.1016/j.taap.2021.115519;
- PII
- S0041008X21001265;
Publishing Information
- Journal Title
- Toxicology and Applied Pharmacology
- Journal Volume
- 419
- Journal Page Range
- vp.
- ISSN
- 0041-008X
- CODEN
- TXAPA9
INIS
- Country of Publication
- United States
- Country of Input or Organization
- International Atomic Energy Agency (IAEA)
- INIS RN
- 54051926
- Subject category
- S60: APPLIED LIFE SCIENCES;
- Descriptors DEI
- ATROPINE; BRAIN; MORTALITY; NERVES; RATS; THERAPY; TOXICITY
- Descriptors DEC
- ALKALOIDS; ANIMALS; AUTONOMIC NERVOUS SYSTEM AGENTS; BODY; CENTRAL NERVOUS SYSTEM; DRUGS; MAMMALS; MEDICINE; NERVOUS SYSTEM; ORGANIC COMPOUNDS; ORGANS; PARASYMPATHOLYTICS; RODENTS; VERTEBRATES
Optional Information
- Copyright
- Copyright (c) 2021 Elsevier Inc. All rights reserved.